Skip to main content
Figure 1 | Molecular Medicine

Figure 1

From: CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer’s Disease

Figure 1

(A, B) Representative sections at 4x magnification reflecting ICC staining sample means in mouse hippocampus (A: J20 CNR2+/+; B: J20 CNR2−/−). (C) Quantification of human amyloid ICC staining in mouse hippocampus using 6E10 monoclonal antibodies. Data are means and 95% confidence intervals. (D) Quantification of human amyloid ICC staining in anterior mouse cortex using 6E10 monoclonal antibodies. Data are means and 95% confidence intervals. (E) Quantification of human amyloid ICC staining in posterior J20 mouse cortex with 6E10 monoclonal antibody. Data are means and 95% confidence intervals. *p < 0.05.

Back to article page

Molecular Medicine

ISSN: 1528-3658